Herbas VPB

Print
EN | LT
LT - CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE
EN - CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 403/12 (2006.01)
C07D 403/12 (2013.01)
A61K 31/501 (2006.01)
A61P 29/00 (2018.01)
A61P 29/00 (2006.01)
European patent
(11) Number of the document 4284796
(13) Kind of document T
(96) European patent application number 22704232.2
Date of filing the European patent application 2022-01-28
(97) Date of publication of the European application 2023-12-06
(45) Date of publication and mention of the grant of the patent 2025-04-16
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2022/014261
Date 2022-01-28
PCT application publication
(87) Number WO 2022/165141
Date 2022-08-04
Priority applications
(30) Number Date Country code
202163143769 P 2021-01-29 US
Inventors
(72)
ROSSO, Victor W. , US
Grantee
(73) Bristol-Myers Squibb Company , Route 206 and Province Line Road, Princeton, NJ 08543, US
Title
(54) CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE
  CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE